[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368437-105":59,"doc-detail-368437-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","t-betcd8-t-cells-govern-anti-pd-1-responses-in-microsatellite-stable-gastric-cancers","T-bet+CD8+ T cells govern anti-PD-1 responses in microsatellite-stable gastric cancers","","More than 90% of advanced gastric cancers are microsatellite-stable (MSS), yet only about 10% of unstratified MSS tumors respond to immune checkpoint inhibitors (ICI). This study uses semi-supervised learning to identify likely ICI responders in MSS gastric cancers, achieving high predictive accuracy. ICI-sensitive tumors show increased T-bet+ CD8+ T cell infiltration and stronger anti-tumor activity, supported by tumor infiltration and cytotoxic molecule secretion. Adoptive transfer enhances anti-tumor immunity and ICI susceptibility in a humanized mouse model, while spatial RNA sequencing indicates a T cell–PD-L1 positive-feedback loop that may drive T cell exhaustion and guide ICI therapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/t-betcd8-t-cells-govern-anti-pd-1-responses-in-microsatellite-stable-gastric-cancers/368437/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/t-betcd8-t-cells-govern-anti-pd-1-responses-in-microsatellite-stable-gastric-cancers/368437.png","ImageObject",300,407,{"name":92,"@type":93},"Jake","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why do microsatellite-stable gastric cancers respond poorly to anti-PD-1 therapy?","Question",{"text":112,"@type":113},"Most advanced gastric cancers are microsatellite-stable (MSS), and only about 10% of unstratified MSS tumors respond to ICIs. The study investigates immune features that explain and predict this heterogeneous response.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the study identify potential ICI responders among MSS gastric cancers?",{"text":117,"@type":113},"It applies semi-supervised learning to stratify likely ICI responders in MSS gastric cancers, reporting high accuracy with an AUC of 0.924.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism links T-bet+ CD8+ T cells to anti-PD-1 response in MSS tumors?",{"text":121,"@type":113},"Spatial RNA sequencing suggests a positive-feedback loop between T-bet+ T cells and PD-L1+ tumor cells, which can drive T cell exhaustion and may be leveraged to improve ICI therapy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368437,1790604302,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article [https://doi.org/10.1038/s41467-025-58958-1](https://doi.org/10.1038/s41467-025-58958-1)  \nT-bet+CD8+ T cells govern anti-PD-1 responses in microsatellite-stable gastric cancers  \nReceived: 25 April 2024  \n\n| Accepted: 4 April 2025 |\n| --- |\n| |\n| Check for updates |\n\nShiying Tang 1,2,3,4,9, Xiaofang Che1,2,3,4,9, Jinyan Wang5, Ce Li1,2,3,4, Xin He1,2,3,4, Kezuo Hou1,2,3,4, Xiaojie Zhang1,2,3,4, Jia Guo1,2,3,4, Bowen Yang1,2,3,4, Danni Li1,2,3,4, Lili Cao1,2,3,4, Xiujuan Qu1,2,3,4,10 , Zhenning Wang 6,7,8,10  &  \nYunpeng Liu 1,2,3,4,10   \nMore than 90% of advanced gastric cancers (GC) are microsatellite-stable (MSS). Compared to the high response rate of immune checkpoint inhibitors (ICI) in microsatellite-instability-high (MSI-H) GCs, only 10% of unstratiﬁed MSS GCs respond to ICIs. In this study, we apply semi-supervised learning tostratify potential ICI responders in MSS GCs, achieving high accuracy, quantiﬁed by an area under the curve of 0.924. Spatial analysis of the tumor microenvironment of ICI-sensitive GCs reveals a high level of T-bet+ CD8 + T cell inﬁltration in their tumor compartments. T-bet+ CD8 + T cells exhibit superior anti-tumor activity due to their increased ability to inﬁltrate tumorsand secrete cytotoxic molecules. Adoptive transfer of T-bet+ CD8 + T cells boosts anti-tumor immunity and confers susceptibility to ICIs in immuneignorant MSS GCs in a humanized mouse model. Spatial RNA sequencing suggests a positive-feedback loop between T-bet+ T cells and PD-L1+ tumor cells, which eventually drives T cell exhaustion and can therefore be leveraged for ICI therapy. In summary, our research provides insights into the underlying mechanism of anti-tumor immunity and deepens our understanding of varied ICI responses in MSS GCs.  \nGastric cancer (GC) is one of the leading causes of cancer-related death globally1. Cytotoxic chemotherapies remain the ﬁrst-line treatment formost advanced GCs; however, the median overall survival (OS) fails to exceed one year2–5. Immune checkpoint inhibitors (ICIs, e.g., PD-1/PD-L1 inhibitors) have shown great promise in multiple solid tumors6,7. InGCs,  \nPD-1 inhibitors have demonstrated a superior anti-tumor activity in Microsatellite instability-high/deﬁcient mismatch repair (MSI-H/dMMR) cancers, with the overall response rates(ORRs)ranging from45%to60%, comparing to 10% ORRs in microsatellite-stable/proﬁcient mismatch repair (MSS/pMMR) GCs8–12. The rationale for a higher response rate in  \n1Department of Medical Oncology, The First Hospital of China Medical University, No. 155, Nanjing Street, Shenyang, Liaoning, China. 2Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, The First Hospital of China Medical University, Shenyang, Liaoning, China. 3Clinical Cancer Research Center of Shenyang, the First Hospital of China Medical University, Shenyang, China. 4Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumours, Ministry of Education, Shenyang, Liaoning, China. 5Department of Immunology, College of Basic Medical Sciences, China Medical University, No. 77, Puhe Road, Shenyang, Liaoning, China. 6Department of Surgical Oncology and General Surgery, The First Hospital of China Medical University, No.155, Nanjing Street, Shenyang, Liaoning, China. 7Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumours, Ministry of Education, China Medical University, Shenyang, Liaoning, China. 8Institute of Health Sciences, China Medical University, Shenyang, Liaoning, China. 9These authors contributed equally: Shiying Tang, Xiaofang Che. 10These authors jointly supervised this work: Xiujuan Qu, Zhenning Wang,  \nYunpeng Liu. e-mail: [xjqu@cmu.edu.cn](xjqu@cmu.edu.cn); [znwang@cmu.edu.cn](znwang@cmu.edu.cn); [ypliu@cmu.edu.cn](ypliu@cmu.edu.cn)  \nTable 1 | Clinical characteristics of patients in GC-ICI cohort  \n\n| Patient ID | MSI | EBV | Subtype | Treatment | BOR | Response | Progression | PFS (days) |\n| --- | --- | --- | --- ","cbCaitaBEd3TJKUZ","https://ap.wps.com/l/cbCaitaBEd3TJKUZ","pdf",13564148,17,"English","# Background\n# Methods and Stratification Approach\n# Immune Microenvironment Findings\n# Functional Validation and Therapeutic Implications\n# Mechanistic Model: T-bet+ T cells and PD-L1 Loop\n# Clinical Cohort Table","[{\"question\":\"Why do microsatellite-stable gastric cancers respond poorly to anti-PD-1 therapy?\",\"answer\":\"Most advanced gastric cancers are microsatellite-stable (MSS), and only about 10% of unstratified MSS tumors respond to ICIs. The study investigates immune features that explain and predict this heterogeneous response.\"},{\"question\":\"How does the study identify potential ICI responders among MSS gastric cancers?\",\"answer\":\"It applies semi-supervised learning to stratify likely ICI responders in MSS gastric cancers, reporting high accuracy with an AUC of 0.924.\"},{\"question\":\"What mechanism links T-bet+ CD8+ T cells to anti-PD-1 response in MSS tumors?\",\"answer\":\"Spatial RNA sequencing suggests a positive-feedback loop between T-bet+ T cells and PD-L1+ tumor cells, which can drive T cell exhaustion and may be leveraged to improve ICI therapy.\"}]","T-bet+CD8+ T cells govern anti-PD-1 responses in microsatellite-stable gastric cancers | PDF",1790176936,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c15e93099e22c238a0cdbc0a0bbb2c1.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/689a5231cbd66c17c9f84f520ea9effa.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2fe09bb46886004eb8b6ef64e5109650.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e596dfa93a44ee97bfe71f174f5ded5.webp",980,1301]